Abstract:Background: Esculentosides and related phytolaccosides form a group of oleanene-type saponins isolated from plants of the Phytolaccaceae family, essentially Phytolacca esculenta, P. americana and P. acinosa. This chemical family offers a diversity of glycosylated compounds, including molecules with a mono-, di- or tri-saccharide unit at position C-3, and with or without a glucose residue at position C-28. The esculentosides, which derive essentially from the sapogenin jaligonic acid or its 30-methyl ester phytolaccagenin, exhibit anti-inflammatory, antifungal and anticancer activities. Purpose: The objective of the review was to identify the 26 esculentosides (ES) and phytolaccosides known to date, including 16 monodesmosidic and 10 bidesmosidic saponins, and to review their pharmacological properties and molecular targets. Methodology: The retrieval of potentially relevant studies was done by systematically searching of scientific databases like Google Scholar and PubMed in January-May 2020. The main keywords used as search terms were related to esculentosides, phytolaccosides and Phytolaccaceae. The systematic search retrieved about 110 papers that were potentially relevant and after an abstract-based selection, 68 studies were analyzed in details and discussed. Results: The structural relationship between the compounds and their sapogenin precursors has been studied. In addition, the pharmacological properties of the main ES, such as ES-A, -B and -H, have been analyzed to highlight their mode of action and potential targets. ES-A is a potent inhibitor of the release of cytokines and this anti-inflammatory activity contributes to the anticancer effects observed in vitro and in vivo. Potential molecular targets of ES-A/B include the enzymes cyclooxygenase 2 (COX-2) and casein kinase 2 (CK2). In addition, the targeting of the protein high-mobility group box 1 (HGMB1) by ES-A/B is proposed, based on molecular modeling and the structural analogy with the related saponin glycyrrhizin, a potent HGMB1 alarmin inhibitor. Conclusion: More work is needed to properly characterize the molecular targets but otherwise compounds like ES-A and ES-H emerge as potent anti-inflammatory and anticancer agents and ES-B as an antifungal agent. A preclinical development of these three compounds should be considered.

Escin’s Phytochemistry and Pharmacy: Biosynthesis, Chemistry, Synergism and Novel Activities

Escin's Multifaceted Therapeutic Profile in Treatment and Post-Treatment of Various Cancers: A Comprehensive Review

β-Escin: An Updated Review of Its Analysis, Pharmacology, Pharmacokinetics, and Toxicity

Therapeutic potential of esculetin in various cancer types (Review)

Multidisciplinary strategies to enhance therapeutic effects of flavonoids from Epimedii Folium: Integration of herbal medicine, enzyme engineering, and nanotechnology

Synergy research: Approaching a new generation of phytopharmaceuticals

A review on medical plants Siegesbeckia based on diterpenoids and sesquiterpenoids: phytochemistry, pharmacology and clinical applications

Pharmacological and Therapeutic Applications of Esculetin

The pharmacological and pharmacokinetic properties of esculin: A comprehensive review

Chemistry and pharmacology of saponins: special focus on cytotoxic properties

Sinensetin: An Insight on Its Pharmacological Activities, Mechanisms of Action and Toxicity

The Chemotherapeutic Potentials of Compounds Isolated from the Plant, Marine, Fungus, and Microorganism: Their Mechanism of Action and Prospects

A Comprehensive Review on Chrysin: Emphasis on Molecular Targets, Pharmacological Actions and Bio-pharmaceutical Aspects

Unlocking the Therapeutic Potentiality of Natural Products in Cancer Therapy: A Recent Update and Current Prospects

Transformative Natural Product-Drug Combinations Pioneering Techniques for Enhanced Efficacy Against Drug-Resistant Pathogens for drug discovery and development.

Advances in pharmacology, biosynthesis, and metabolic engineering of Scutellaria-specialized metabolites

Synthetic Investigation toward Acyl Group‐Free Escin Derivatives

Total Synthesis of Complex Natural Products: Combination of Chemical Synthesis and Biosynthesis Strategies

Esculentosides: Insights into the potential health benefits, mechanisms of action and molecular targets

What Does It Take to Synergistically Combine Sub-Potent Natural Products into Drug-Level Potent Combinations?

Schisandraceae triterpenoids: A review of phytochemistry, bioactivities and synthesis